IPF Diagnosis, Monitoring Could Be Done Via Noninvasive Nasal Sampling

This topic contains 0 replies, has 1 voice, and was last updated by  Pulmonary Fibrosis News Moderator 9 months ago.

  • Author
  • #15743

    The nasal epithelium of patients with idiopathic pulmonary fibrosis (IPF) shows different levels of gene expression implicated in inflammatory and immune responses than those without the disease, a study reports.

    According to the researchers, these findings support nasal sampling as a noninvasive and inexpensive approach to identify and monitor IPF patients. Read more about this topic here.

    Would you like to try nasal sampling? Do you think it would be more comfortable to undergo as a patient?

You must be logged in to reply to this topic.

Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?


Create Account